JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.12 Cr | ₹2.98 Cr | ₹3.24 Cr | ₹3.92 Cr | ₹3.99 Cr |
What is the latest Total Non-Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.12 Cr |
| Mar2024 | ₹2.98 Cr |
| Mar2023 | ₹3.24 Cr |
| Mar2022 | ₹3.92 Cr |
| Mar2021 | ₹3.99 Cr |
How is Total Non-Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.12 Cr | 38.12 | |
| Mar2024 | ₹2.98 Cr | -7.82 | |
| Mar2023 | ₹3.24 Cr | -17.36 | |
| Mar2022 | ₹3.92 Cr | -1.81 | |
| Mar2021 | ₹3.99 Cr | - | |
Compare Total Non-Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹496.2 Cr | -1.9% | -2.3% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -1.9% |
-2.3% |
-15.7% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses